For example, PD-L1 expression is regulated by oncogenic drivers, e.g. epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) in NSCLC [12]. Here, EGFR is linked to non-small cell lung carcinoma.